140 related articles for article (PubMed ID: 35581059)
1. A CRISPR view on autophagy.
Liang JR; Corn JE
Trends Cell Biol; 2022 Dec; 32(12):1008-1022. PubMed ID: 35581059
[TBL] [Abstract][Full Text] [Related]
2. Is Pooled CRISPR-Screening the Dawn of a New Era for Functional Genomics.
Yao J; Dai HL
Adv Exp Med Biol; 2018; 1068():171-176. PubMed ID: 29943304
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
[TBL] [Abstract][Full Text] [Related]
4. Cancer CRISPR Screens In Vivo.
Chow RD; Chen S
Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
[TBL] [Abstract][Full Text] [Related]
5. Diving into marine genomics with CRISPR/Cas9 systems.
Momose T; Concordet JP
Mar Genomics; 2016 Dec; 30():55-65. PubMed ID: 27742404
[TBL] [Abstract][Full Text] [Related]
6. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
7. Genetic screens and functional genomics using CRISPR/Cas9 technology.
Hartenian E; Doench JG
FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
9. Advances and perspectives on the use of CRISPR/Cas9 systems in plant genomics research.
Liu D; Hu R; Palla KJ; Tuskan GA; Yang X
Curr Opin Plant Biol; 2016 Apr; 30():70-7. PubMed ID: 26896588
[TBL] [Abstract][Full Text] [Related]
10. The applications of CRISPR screen in functional genomics.
Qi X; Zhang J; Zhao Y; Chen T; Xiang Y; Hui J; Cai D; Liu Y; Xia L; Yu T; Li G
Brief Funct Genomics; 2017 Jan; 16(1):34-37. PubMed ID: 27329784
[TBL] [Abstract][Full Text] [Related]
11. Decoding the noncoding genome via large-scale CRISPR screens.
Shukla A; Huangfu D
Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
[TBL] [Abstract][Full Text] [Related]
12. Puncta intended: connecting the dots between autophagy and cell stress networks.
Ho CJ; Samarasekera G; Rothe K; Xu J; Yang KC; Leung E; Chan M; Jiang X; Gorski SM
Autophagy; 2021 Apr; 17(4):1028-1033. PubMed ID: 32507070
[TBL] [Abstract][Full Text] [Related]
13. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
14. CRISPR screening using an expanded toolkit of autophagy reporters identifies TMEM41B as a novel autophagy factor.
Shoemaker CJ; Huang TQ; Weir NR; Polyakov NJ; Schultz SW; Denic V
PLoS Biol; 2019 Apr; 17(4):e2007044. PubMed ID: 30933966
[TBL] [Abstract][Full Text] [Related]
15. A CRISPR view of hematopoietic stem cells: Moving innovative bioengineering into the clinic.
Worthington AK; Forsberg EC
Am J Hematol; 2022 Sep; 97(9):1226-1235. PubMed ID: 35560111
[TBL] [Abstract][Full Text] [Related]
16. The application of genome-wide CRISPR-Cas9 screens to dissect the molecular mechanisms of toxins.
Wang B; Chen JZ; Luo XQ; Wan GH; Tang YL; Wang QP
Comput Struct Biotechnol J; 2022; 20():5076-5084. PubMed ID: 36187925
[TBL] [Abstract][Full Text] [Related]
17. Interrogating immune cells and cancer with CRISPR-Cas9.
Buquicchio FA; Satpathy AT
Trends Immunol; 2021 May; 42(5):432-446. PubMed ID: 33812776
[TBL] [Abstract][Full Text] [Related]
18. Tutorial: design and execution of CRISPR in vivo screens.
Braun CJ; Adames AC; Saur D; Rad R
Nat Protoc; 2022 Sep; 17(9):1903-1925. PubMed ID: 35840661
[TBL] [Abstract][Full Text] [Related]
19. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
[TBL] [Abstract][Full Text] [Related]
20. In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
Dubrot J; Lane-Reticker SK; Kessler EA; Ayer A; Mishra G; Wolfe CH; Zimmer MD; Du PP; Mahapatra A; Ockerman KM; Davis TGR; Kohnle IC; Pope HW; Allen PM; Olander KE; Iracheta-Vellve A; Doench JG; Haining WN; Yates KB; Manguso RT
Immunity; 2021 Mar; 54(3):571-585.e6. PubMed ID: 33497609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
